Protective Effects of Gallic Acid Against Chronic Restraint Stress-Induced Histological Alterations of Skin

Öz

Aim: Stress is a situation that living beings face at every stage. It has been called the pandemic of our time and plays a role in the pathogenesis of many diseases. Chronic activation of the hypothalamic-pituitary-adrenal (HPA) axis in response to stress leads to increased tissue inflammation and reactive oxygen species (ROS). Many inflammatory skin conditions, such as atopic dermatitis and psoriasis, are triggered or exacerbated by stress. In our study, chronic restraint stress, a physical and mental stress model, was used to investigate the protective effect of gallic acid (GA) against the damage induced by this model in rat skin at the morphological level. Method: Subjects were divided into four equal groups (n=7): Control (C), Chronic Stress (CS), and Chronic Stress+Gallic Acid (CS+GA). Histologic sections from each group were stained with hematoxylin-eosin (H-E), Masson trichrome, and toluidine blue. Results: In the CS group, there was a decrease in epidermal thickness, losses in epidermal cell morphology, and a detachment of collagen integrity. Concurrently, there was an increase in mast cell count and anti-IL-6 immunohistochemical positivity. In the CS+GA group, epidermal thickness, inflammation, and collagen structure parameters were similar to the CS group. Anti-IL-6 immunohistochemical positivity was significantly decreased compared to the CS group. Conclusion: According to our findings, gallic acid morphologically reduced the damage caused by chronic immobility stress on the skin mucosa. Given these findings, different studies may use gallic acid as a protective adjuvant in stress-induced skin damage.

Anahtar Kelimeler

• Skin
• Chronic Restraint Stress
• Gallic acid
• Oxidative stress

Protective Effects of Gallic Acid Against Chronic Restraint Stress-Induced Histological Alterations of Skin

Öz

Giriş ve Amaç: Stres, canlıların yaşamın her aşamasında karşılaştığı bir durumdur. Günümüzün pandemisi olarak nitelendirilen stres, pek çok hastalığın patogenezinde rol oynar. Hipotalamus-Hipofiz-Adrenal (HPA) ekseninin stres karşısında kronik aktivasyonu, dokulardaki inflamatuar yanıtın ve reaktif oksijen türlerinin (ROS) artmasına neden olur. Atopik dermatit, sedef hastalığı gibi birçok inflamatuar deri hastalığı stresi ile tetiklenir ya da kötüleşir. Çalışmamızda fiziksel ve mental stres modeli olan kronik kısıtlama stresi kullanılmış ve bu modelin sıçan derisinde neden olduğu hasara karşı gallik asit (GA)’in koruyucu etkisi morfolojik düzeyde araştırılmıştır. Gereç ve Yöntemler: Denekler 4 eşit gruba ayrılmıştır (n=7): Kontrol (K), Kronik Stres (KS) ve Kronik Stres+Gallik Asit (KS+GA). Her gruptan alınan histolojik kesitler hematoksilen-eozin (H-E), Masson trikrom ve toluidin mavisi ile boyanmıştır. Bulgular: KS grubunda epidermal kalınlıkta azalma, epidermal hücre morfolojilerinde bozulmalar, kollajen bütünlüğünde kayıplar, mast hücre sayısı ve anti-IL-6 immünohistokimyasal pozitivite artışı görüldü. KS+GA grubunda ise epidermal kalınlık, inflamasyon ve kollajen organizasyonunun K grubu ile benzerlik gösterdiği görüldü. Anti-IL-6 immünohistokimyasal pozitivitenin KS grubuna kıyasla anlamlı düzeyde azaldığı görüldü. Sonuç: Bulgularımıza göre gallik asitin, kronik hareketsizlik stresinin deride meydana getirdiği hasarı morfolojik olarak azalttığı görülmüştür. Bu bulguların ışığında yapılacak farklı çalışmalar ile stres kaynaklı deri hasarlarında, gallik asit koruyucu bir yardımcı ajan olarak kullanılabilir.

Anahtar Kelimeler

• Deri
• Kısıtlama stresi
• Gallik asit
• Oksidatif stres

Kaynakça

1. Fink, G., Stress: Concepts, Definition and History, Reference Module Inneuroscience and Biobehavioral Psychology, 2017, 1-9.
2. 2. Chrousos GP, Stress and disorders of the stress system, Nat Rev Endocrinol, 2009,5,374–81.
3. 3. Wingfield JC, Sapolsky RM, Reproduction and stress resistance: when and how, J Neuroendocrinol, 2003,15,711–24.
4. 4. Dhabhar FS, Psychological stress and immunoprotection versus immunopathology in the skin, Clinics in Dermatology, 2013,31,18–30.
5. 5. Xu C, Lee SK, Zhang D, Frenette PS, The gut microbiome regulates psychological stress-induced inflammation, Immunity, 2020, 53,417-428.e4.
6. 6. Tsigos C, Chrousos GP, Hypothalamic–pituitary–adrenal axis, neuroendocrine factors and stress, Journal of Psychosomatic Research, 2002,53,865–71.
7. 7. Slominski A, Wortsman J, Tuckey RC, Paus R, Differential expression of HPA axis homolog in the skin, Mol Cell Endocrinol, 2007,265–266,143–9.
8. 8. Tsuchiya T, Horii I, Epidermal cell proliferative activity assessed by proliferating cell nuclear antigen (PCNA) decreases following immobilization-induced stress in male Syrian hamsters, Psychoneuroendocrinology, 1996,21:111–7.

9. 9. Denda M, Tsuchiya T, Elias PM, Feingold KR. Stress alters cutaneous permeability barrier homeostasis, Am J Physiol Regul Integr Comp Physiol 2000, 278, R367-372.
10. 10. Garg A, Chren MM, Sands LP, Matsui MS, Marinus KD, Feingold KR, ve ark., Psychological Stress Perturbs Epidermal Permeability Barrier Homeostasis: Implications for the Pathogenesis of Stress-Associated Skin Disorders, Archives of Dermatology, 2001,137,53–9.
11. 11. Hall JMF, Cruser D, Podawiltz A, Mummert DI, Jones H, Mummert ME, Psychological Stress and the Cutaneous Immune Response: Roles of the HPA Axis and the Sympathetic Nervous System in Atopic Dermatitis and Psoriasis, Dermatol Res Pract 2012,2012, 403908.
12. 12. Amano H, Negishi I, Akiyama H, Ishikawa O, Psychological stress can trigger atopic dermatitis in NC/Nga mice: an inhibitory effect of corticotropin-releasing factor, Neuropsychopharmacology 2008,33,566–73.
13. 13. Basavaraj KH, Navya MA, Rashmi R, Stress and quality of life in psoriasis: an update, Int J Dermatol, 2011,50,783–92.
14. 14. Alexopoulos A, Chrousos GP, Stress-related skin disorders, Rev Endocr Metab Disord, 2016, 17, 295–304.
15. 15. Cikler E, Ercan F, Cetinel S, Contuk G, Sener G, The protective effects of melatonin against water avoidance stress-induced mast cell degranulation in dermis, Acta Histochem, 2005,106,467–75.
16. 16. Trouba KJ, Hamadeh HK, Amin RP, Germolec DR, Oxidative stress and its role in skin disease, Antioxid Redox Signal, 2002, 4, 665–73.
17. 17. Liu N, Wang LH, Guo LL, Wang GQ, Zhou XP, Jiang Y, et al., Chronic Restraint Stress Inhibits Hair Growth via Substance P Mediated by Reactive Oxygen Species in Mice, PLoS One, 2013,8,e61574.
18. 18. Theoharides TC, The impact of psychological stress on mast cells, Ann Allergy Asthma Immunol, 2020,125,388–92.
19. 19. Pondeljak N, Lugović-Mihić L, Stress-induced Interaction of Skin Immune Cells, Hormones, and Neurotransmitters, Clinical Therapeutics, 2020,42,757–70.
20. 20. Crompton R, Clifton VL, Bisits AT, Read MA, Smith R, Wright IMR, Corticotropin-releasing hormone causes vasodilation in human skin via mast cell-dependent pathways, J Clin Endocrinol Metab, 2003, 88,5427–32.
21. 21. Castagliuolo I, Lamont JT, Qiu B, Fleming SM, Bhaskar KR, Nikulasson ST, et al., Acute stress causes mucin release from rat colon: role of corticotropin releasing factor and mast cells, Am J Physiol, 1996, 271, G884-892.
22. 22. Huang M, Berry J, Kandere K, Lytinas M, Karalis K, Theoharides TC, Mast Cell Deficient W/Wv Mice Lack Stress-Induced Increase in Serum IL-6 Levels, as well as in Peripheral CRH and Vascular Permeability, a Model of Rheumatoid Arthritis, Int J Immunopathol Pharmacol, 2002,15,249–54.
23. 23. Ilves T, Harvima IT, Decrease in Chymase Activity is Associated with Increase in IL-6 Expression in Mast Cells in Atopic Dermatitis, Acta Dermato-Venereologica, 2015,95,411–6.
24. 24. Suttle MM, Nilsson G, Snellman E, Harvima IT, Experimentally induced psoriatic lesion associates with interleukin (IL)-6 in mast cells and appearance of dermal cells expressing IL-33 and IL-6 receptor, Clin Exp Immunol, 2012,169,311–9.
25. 25. Zou Z, Xiao N, Chen Z, Lin X, Li Y, Li P, et al., Yeast Extract Peptides Alleviate Depression in Chronic Restraint Stress Rats by Alleviating Hippocampal Neuronal Apoptosis and Dysbiosis of the Gut Microbiota, Molecular Nutrition & Food Research, 2024,68,2300467.
26. 26. Metz GA, Jadavji NM, Smith LK, Modulation of motor function by stress: a novel concept of the effects of stress and corticosterone on behavior, European Journal of Neuroscience, 2005,22,1190–200.
27. 27. Zucchi FCR, Kirkland SW, Jadavji NM, van Waes LT, Klein A, Supina RD, et al., Predictable stress versus unpredictable stress: A comparison in a rodent model of stroke, Behavioural Brain Research, 2009,205,67–75.
28. 28. Yargiçoğlu P, Yaraş N, Ağar A, Gümüşlü S, Bilmen S, Özkaya G, The effect of vitamin E on stress-induced changes in visual evoked potentials (VEPs) in rats exposed to different experimental stress models, Acta Ophthalmologica Scandinavica, 2003,81,181–7.
29. 29. Mukhina AYu, Mishina ES, Bobyntsev II, Medvedeva OA, Svishcheva MV, Kalutskii PV, et al., Morphological Changes in the Large Intestine of Rats Subjected to Chronic Restraint Stress and Treated with Selank, Bull Exp Biol Med, 2020,169,281–5.
30. 30. Rajan VK, Muraleedharan K, A computational investigation on the structure, global parameters and antioxidant capacity of a polyphenol, Gallic acid, Food Chemistry, 2017, 220, 93–9.
31. 31. Sharifee F, Asadpour L, Shariati S, Salehzadeh A, Facilitation of infectious and non-infectious wound healing using Morus nigra fruit extract ointment: An in vitro and in vivo study, International Immunopharmacology, 2024,134,112230.
32. 32. Zamudio-Cuevas Y, Andonegui-Elguera MA, Aparicio-Juárez A, Aguillón-Solís E, Martínez-Flores K, Ruvalcaba-Paredes E, et al., The enzymatic poly(gallic acid) reduces pro-inflammatory cytokines in vitro, a potential application in inflammatory diseases, Inflammation, 2021,44,174–85.
33. 33. Bai J, Zhang Y, Tang C, Hou Y, Ai X, Chen X, et al., Gallic acid: Pharmacological activities and molecular mechanisms involved in inflammation-related diseases, Biomedicine & Pharmacotherapy, 2021,133,110985. 34. Aziz El Sheikh AA, Moustafa NH, El-Shafey NM, Immunological, histological and immunohistochemical alternations induced by zinc oxide nanoparticles and mureer plant in spleen albino rats with the prospective anti-inflammatory action of gallic acid, Pak J Pharm Sci, 2024,37,1–8.
34. 35. Zhou J, Zhang C, Sun Y, Wang L, Zhang J, Li F, et al., Corilagin Attenuates Allergy and Anaphylactic Reaction by Inhibiting Degranulation of Mast Cells, Med Sci Monit, 2018,24,891–6.
35. 36. Wen L, Tang L, Zhang M, Wang C, Li S, Wen Y, et al., Gallic Acid Alleviates Visceral Pain and Depression via Inhibition of P2X7 Receptor, Int J Mol Sci, 2022,23,6159.
36. 37. Souza BR, Santos JS, Costa AM. Blockade of β1- and β2-Adrenoceptors Delays Wound Contraction And Re-epithelialization In Rats, Clinical and Experimental Pharmacology and Physiology, 2006,33,421–30.
37. 38. Wang C, Yuan J, Wu H xun, Chang Y, Wang Q tong, Wu Y jing, et al., Total glucosides of paeony inhibit the inflammatory responses of mice with allergic contact dermatitis by restoring the balanced secretion of pro-/anti-inflammatory cytokines, International Immunopharmacology, 2015,24,325–34.
38. 39. de Oliveira, P.H.C., Gomes Filho, J.E., Rodrigues, M.J.d., da Silva, C.C., Cardoso, C.d.B. & Cosme daSilva, L. Influence of supplement administration of omega-3 on the subcutaneous tissue response of endodontic sealers in Wistar rats, 2022, International Endodontic Journal, 55, 1026–1041.
39. 40. Arck P, Paus R, From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch, Neuroimmunomodulation, 2006, 13, 347–56.
40. 41. Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB, Reactive Oxygen Species in Inflammation and Tissue Injury, Antioxid Redox Signal, 2014,20,1126–67.
41. 42. Căruntu C, Boda D, Musat S, Căruntu A, Mandache E, Stress-induced mast cell activation in glabrous and hairy skin, Mediators Inflamm, 2014,2014,105950.
42. 43. Ishida H, Mitsui K, Nukaya H, Matsumoto K, Tsuji K, Study of Active Substances Involved in Skin Dysfunction Induced by Crowding Stress. I. Effect of Crowding and Isolation on Some Physiological Variables, Skin Function, and Skin Blood Perfusion in Hairless Mice, Biological and Pharmaceutical Bulletin, 2003,26,170–81.
43. 44. Wagenvoort CA, Zondervan PE, Polyalveolar lobe and congenital cystic adenomatoid malformation type II: are they related? Pediatr Pathol, 1991,11,311–20.
44. 45. SUÁREZ AL, FERAMISCO JD, KOO J, STEINHOFF M, Psychoneuroimmunology of Psychological Stress and Atopic Dermatitis: Pathophysiologic and Therapeutic Updates, Acta Derm Venereol, 2012,92,7–15.
45. 46. Singh LK, Pang X, Alexacos N, Letourneau R, Theoharides TC, Acute Immobilization Stress Triggers Skin Mast Cell Degranulation via Corticotropin Releasing Hormone, Neurotensin, and Substance P: A Link to Neurogenic Skin Disorders, Brain, Behavior, and Immunity, 1999,13,225–39.
46. 47. Lacina L, Kolář M, Pfeiferová L, Gál P, Smetana K, Wound healing: insights into autoimmunity, aging, and cancer ecosystems through inflammation and IL-6 modulation, Front Immunol, 2024,15,1403570.
47. 48. Ragipoglu D, Dudeck A, Haffner-Luntzer M, Voss M, Kroner J, Ignatius A, et al., The Role of Mast Cells in Bone Metabolism and Bone Disorders, Front Immunol, 2020,11,163.
48. 49. Fukada M, Kano E, Miyoshi M, Komaki R, Watanabe T, Effect of ‘rose essential oil’ inhalation on stress-induced skin-barrier disruption in rats and humans, Chem Senses, 2012,37,347–56.
49. 50. Md Jaffri J, Reactive Oxygen Species and Antioxidant System in Selected Skin Disorders, Malays J Med Sci, 2023,30,7–20.
50. 51. Choi EH, Brown BE, Crumrine D, Chang S, Man MQ, Elias PM, et al., Mechanisms by Which Psychologic Stress Alters Cutaneous Permeability Barrier Homeostasis and Stratum Corneum Integrity, Journal of Investigative Dermatology, 2005,124,587–95.
51. 52. Donato-Trancoso A, Cristina de Souza Ribeiro B, Barrozo do Canto F, de Souza Nogueira J, Romana-Souza B, Chronic psychological stress aggravates psoriasis-like skin inflammation via overactivation of β2-adrenoceptor and nuclear factor kappa B pathways, Scandinavian Journal of Immunology, 2023,97,e13258.